A portfolio of fully-integrated diagnostic assays for early detection of disease
We are different
- Flexible Chemistry Platform
- Suite of Composition of Matter Intellectual Property
- High Optical Sensitivity Dyes for Biomolecule Reporters
- In situ sensors generated with nanoparticles
- Capable of high accuracy and precision
Source of image: Bartolowits,M. D., Xin, M., Petrov, D. P., Thomas J. Tague, Jr., T. J.; Davisson, V. J. (2019) “Multimeric Rhodamine Dye-Induced Aggregation of Silver Nanoparticles for Surface-Enhanced Raman Scattering” ACS Omega4 (1) 140–145 PMID 30729221
Lead assay addressing the need for earlier detection of Pancreatic Cancer
- Scalable platform with several assay candidates in development
- Initial focus in Oncology
- PanCystProTM lead assay
- Early diagnosis of pancreatic cancer = huge unmet medical need
Stage
- Working prototype and proof of concept data using clinical sample
- Accomplishments
- Purdue Foundry Black and Gold Awards ($100,000 total)
- NSF Grant awardee
- MedCity Invest Chicago – selected diagnostic track presenter 2020
- bioLogic Innovation Award Finalist 2019
- Texas Lifescience Forum featured pitch 2019
- Innovation Showcase featured pitch- Venture Club of Indiana Finalist 2019
- Inaugural class of the Origins accelerator program sponsored by Elevate Ventures 2019